Vanja Ivancevic is the leader of the BRCCH-funded DAVINCI project and will be supporting the team with regard to project and study management. She received her master’s degree in molecular biology with a major in infection biology from the Biozentrum of the University of Basel in February 2019. After that, she joined Hemex’s clinical operations team, where she supports the team with clinical study design development and with submitting clinical studies of medical devices and pharmaceuticals to regulatory authorities and ethics committees. She also plays a key role in managing and writing grant applications and in supporting companies with the requirement and implementation of coaching programmes.